Moderna Halts Plans for Kenyan mRNA Vaccine Plant After Taking $1B Financial Hit

Moderna said it paused plans to build an mRNA manufacturing facility in Kenya Thursday in an effort to provide additional time to assess demand for vaccines after suffering $1 billion in losses and write-downs linked to canceled orders.